Other studies have reported evidence of chromosomal abnormalities in IMT at locus 2 of chromosome 23, leading to gene rearrangements involving the anaplastic lymphoma kinase (ALK) gene, suggesting a neoplastic rather than a reactive origin [7,9]. The gene discussed is ALK; the disease is inflammatory myofibroblastic tumor.